Related Experiment Video
Updated: May 7, 2026

Isolation of Culturable Yeasts and Molds from Soils to Investigate Fungal Population Structure
Published on: May 27, 2022
Azole resistance in Aspergillus fumigatus: a growing public health concern
Edith Vermeulen1, Katrien Lagrou, Paul E Verweij
1aDepartment of Microbiology and Immunology, Catholic University of Leuven bDepartment of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium cDepartment of Medical Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.
Purpose Of Review:
Reports from the end of the 2000s forced the medical community to take azole resistance in Aspergillus fumigatus into account. Not only patients with chronic aspergillus disease, who develop resistance during long-term azole treatment, but also azole-naive patients are at risk, owing to the presence of resistant strains in the environment. The purpose of this review is to overview the latest findings concerning the origin, evolution, and implications of azole resistance in A. fumigatus.
Recent Findings:
TR34/L98H is the predominant resistance mechanism of environmental origin in A. fumigatus. Recent epidemiological data show that this mechanism is an expanding problem, with reports from China, Iran, and India. However, the TR34/L98H strains from the Middle East are genotypically different from the European isolates; their emergence is, therefore, not due to simple geographical spread of the 'European' isolates. A new environmental resistance mechanism, TR46/Y121F/T289A, was detected in the Netherlands, conferring voriconazole resistance. In patients chronically treated with triazoles, the spectrum of resistance has become more diverse, with the emergence of non-CYP51A-mediated mechanisms. Central registration of treatment and outcome data of patients with resistant aspergillus disease are needed.
Summary:
Azole resistance in A. fumigatus is evolving to a global health problem.
Insights
Azole resistance in Aspergillus fumigatus is a growing global health concern. Environmental and patient-derived resistant strains, like TR34/L98H, are increasingly reported worldwide, necessitating further research and data collection.
Area of Science:
- Medical Mycology
- Antimicrobial Resistance
- Fungal Pathogenesis
Background:
- Azole resistance in Aspergillus fumigatus emerged as a significant clinical concern in the late 2000s.
- Both chronically treated and azole-naive patients are at risk due to resistant environmental strains.
- Understanding the origin and evolution of resistance is crucial for managing invasive fungal infections.
Purpose of the Study:
- To review the latest findings on the origin, evolution, and implications of azole resistance in Aspergillus fumigatus.
- To highlight the increasing prevalence and geographical spread of resistant strains.
- To discuss emerging resistance mechanisms and the need for better data management.
Main Methods:
- Literature review of recent epidemiological and molecular studies on azole resistance in A. fumigatus.
- Analysis of reported resistance mechanisms, including CYP51A-mediated and non-CYP51A-mediated pathways.
- Synthesis of data on the geographical distribution and genotypic variations of resistant isolates.
Main Results:
- TR34/L98H is the predominant environmental resistance mechanism, with expanding reports globally.
- Genotypic differences exist between Middle Eastern and European TR34/L98H strains, suggesting independent emergence.
- A novel environmental resistance mechanism, TR46/Y121F/T289A, confers voriconazole resistance.
- Patient resistance mechanisms are diversifying beyond CYP51A-mediated pathways.
Conclusions:
- Azole resistance in Aspergillus fumigatus is a rapidly evolving global health problem.
- Continuous monitoring and characterization of resistant strains are essential.
- Centralized registration of treatment and outcome data for patients with resistant aspergillosis is needed.
More Related Videos
09:52Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
15:01Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung
Published on: September 18, 2021
Related Concept Videos
Fungal Phylum Ascomycota
Fungal Phylum Microsporidia
Fungal Group Zygomycota
Antifungal Agents